Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Acadia Pharmaceutica
(NQ:
ACAD
)
17.17
+0.46 (+2.75%)
Streaming Delayed Price
Updated: 1:44 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Acadia Pharmaceutica
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 05, 2021
Gainers Ensysce Biosciences (NASDAQ:ENSC) shares rose 42.78% to $5.84 during Thursday's pre-market session. The company's market cap stands at $141.7 million....
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
26 Stocks Moving in Thursday's Pre-Market Session
August 05, 2021
Gainers Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares rose 34% to $5.48 in pre-market trading after dropping around 15% on Wednesday. Ensysce Biosciences recently appointed...
Via
Benzinga
10 Stocks Moving In Wednesday's After-Hours Session
August 04, 2021
Gainers MercadoLibre (NASDAQ: MELI) shares are trading higher after the company reported Q2 EPS of $1.37, up from $1.11 year over year and better-than-expected Q2 sales results....
Via
Benzinga
Earnings Scheduled For May 5, 2021
May 05, 2021
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 04, 2021
Gainers Scopus BioPharma (NASDAQ:SCPS) s...
Via
Benzinga
9 Monster Stock Market And Earnings Predictions – Sunday, August 1
August 01, 2021
Stocks finished the week of July 30 lower, dropping by 40 bps and while the S&P 500 didn’t finish down all that much, we could wonder if last week served as a turning point for the market overall.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Understanding ACADIA Pharmaceuticals's Unusual Options Activity
July 19, 2021
Shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved down to $23.25. Sentiment:...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
July 01, 2021
Gainers Alterity Therapeutics (NASDAQ:ATHE
Via
Benzinga
Best and Worst Russell 1000 Stocks So Far in June
June 16, 2021
Right at the midpoint of June, Biogen has been the top-performing Russell 1,000 stock month to date.
Via
Talk Markets
10 Monster Stock Market Predictions For The Week Of June 14
June 13, 2021
The big question is what’s next for the S&P 500. Monday morning will likely decide what happens next. It would not be surprising to a reversion to the beginning of the wedge at 4070 over the next...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
What 18 Analyst Ratings Have To Say About ACADIA Pharmaceuticals
June 10, 2021
Analysts have provided the following ratings for ACADIA Pharmaceuticals (NASDAQ:ACAD) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 10, 2021
June 10, 2021
Upgrades According to Argus Research, the prior rating for Zoom Video Communications Inc (NASDAQ:ZM) was changed from Hold to Buy. Zoom Video Communications earned $1.32...
Via
Benzinga
Bitcoin May Be Ready To Melt As It Nears Another Massive Breaking Point
June 07, 2021
It was another rather boring day, with the S&P 500 finishing basically flat down 8 bps. The Nasdaq 100 had the better day.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Stocks Drop On May 5 As Inflation Rises And Growth Slows
May 05, 2021
Stocks finished mostly lower, with the S&P 500 up just 7 bps, while the Qs fell by almost 35 bps. The index had been higher nearly all day and fell sharply going into the final hour of trading.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Cramer Gives His Opinion On Lemonade, Pinterest And More
May 02, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said he still likes Lemonade Inc (NYSE: LMND). Investors will have to wait a long time for the value of the stock...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
May 01, 2021
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...
Via
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
May 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 20, 2021
Gainers Artelo Biosciences (NASDAQ:ARTL) stock rose 5.26% to $1.2 during Tuesday's after-market session. This security traded at a volume of 43.6K shares come close, making up...
Via
Benzinga
The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug
April 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 12) 180 Life Sciences Corp. (...
Via
Benzinga
Exposures
Product Safety
Stocks That Hit 52-Week Lows On Monday
April 12, 2021
Before 10 a.m. ET on Monday, 30 stocks hit new 52-week lows. Interesting Highlights: The largest company by market cap to set a new 52-week low was Ionis Pharmaceuticals (...
Via
Benzinga
The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
April 10, 2021
Contrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. The weakness partly reflected a preference for risky bets at the expense of...
Via
Benzinga
Exposures
Product Safety
Stocks That Hit 52-Week Lows On Friday
April 09, 2021
On Friday morning, 13 companies achieved new lows for the year. Intriguing Points: The largest company by market cap to set a new 52-week low was Cia Paranaense De...
Via
Benzinga
Biotech Stocks Hit A Snag — Why Experts Say The Heyday Isn't Over
April 09, 2021
Regulatory and drug-pricing worries have knocked biotech stocks off their pedestal. After hitting a high point in February, biotech stocks have fallen 20%.
Via
Investor's Business Daily
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2021
April 07, 2021
Upgrades According to Janney Capital, the prior rating for Texas Capital Bancshares Inc (NASDAQ:TCBI) was changed from Neutral to Buy. Texas Capital Bancshares earned $1....
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
April 07, 2021
Keybanc raised Applied Materials, Inc. (NASDAQ: AMAT) price target from $144 to $151. Applied Materials shares rose 0.1% to $139.65 in pre-market trading. Needham boosted SMART...
Via
Benzinga
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award
April 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 6) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
After FDA Rejects Acadia Dementia Drug, Analysts Lament Lack Of Near-term Stock Drivers
April 06, 2021
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares came under pressure Monday after the Food and Drug Administration (FDA) rejected its regulatory application seeking label...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.